FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period

HEMOGENYX PHARMACEUTICALS PLC: ifrs:CashFlowsFromUsedInFinancingActivities

One fact, its scope and the complete path back to the official record.

Period: 2021-10-01 – 2022-09-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/fd835a1f-babc-4054-bbe3-2d7171283925

Reported value

4.378M{"amount": 4378000.0}
Entity
HEMOGENYX PHARMACEUTICALS PLC
Metric
ifrs:CashFlowsFromUsedInFinancingActivities
Period
2021-10-01 – 2022-09-30
Status
current
Source
ESEF — Europäische Jahresabschlüsse (iXBRL)

Provenance

Official referenceesef:2138008L93GYU5GN6179:2022-09-30
Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:14:21.306713+02:00
Raw response SHA-25656945fbb3ca7423ed82f34ced12245c4…
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies